Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series

Ofatumumab successfully treats myelin oligodendrocyte glycoprotein antibody-associated disease accompanied by Epstein-Barr viral infection: a case series

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) caused by pathogenic immunoglobulin G antibodies to myelin oligodendrocyte glycoprotein is a rare demyelinating disease of the central nerve system (CNS). The clinical phenotypes of MOGAD include acute disseminated encephalomyel...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chen Min, Bi Zhuajin, Liu Peidong, Li Ruoyu, Liu Ju, Liu Hongbo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	MOG-IgG associated encephalitis Epstein-Barr virus ofatumumab neuron damage case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1510097/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Plasma Epstein-Barr Virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr Virus infection
by: Chunxiang Ma, et al.
Published: (2025-01-01)

Interplay of aurora kinase a functional residues and Epstein-barr Nuclear Antigen 1 in Epstein-barr virus associated Gastric cancer using AGS cells
by: Nidhi Varshney, et al.
Published: (2025-01-01)

Infarct‐like myocarditis with coronary vasculitis and aneurysm formation caused by Epstein–Barr virus infection
by: Cristina Chimenti, et al.
Published: (2020-06-01)

Age-related immunosenescence and Epstein–Barr virus-positive mucocutaneous ulcer presenting as oral cancer: a case report
by: Jiayuan Ye, et al.
Published: (2025-01-01)

Retrospective Investigation of Cytomegalovirus and Epstein–Barr Virus Positivity in Inflammatory Bowel Disease Patient Biopsies
by: Hasan Bostancı, et al.
Published: (2024-01-01)

Myelitis associated with glial fibrillary acidic protein IgG: characterization and comparison with aquaporin-4 IgG and myelin oligodendrocyte glycoprotein IgG myelitis
by: Yinyin Xie, et al.
Published: (2025-01-01)

鼻咽癌(NPC)早期发现中的Epstein-Barr病毒脱氧核糖核酸酶抗体血清学研究
Published: (1992-01-01)

Comparison between ELISA and PCR for Detection of Epstein - Barr virus in children with acute cervical lymphadenitis
by: Nazim Khan, et al.
Published: (2024-11-01)

Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development
by: Arezoo Esmaeili, et al.
Published: (2024-01-01)

Epstein-Barr virus (EBV) and systemic lupus erythematosus (SLE) association in serological studies
by: Witold Czyż, et al.
Published: (2025-01-01)

The trend of Epstein-Barr virus DNA loads and CD8+ T lymphocyte numbers can predict the prognosis of pediatric liver transplant recipients with PTLD
by: Wang Kedi, et al.
Published: (2025-02-01)

Chronic active Epstein‒Barr virus colitis, a rare cause of recurrent diarrhea in an immunocompetent female: a case report
by: Mei Liang, et al.
Published: (2025-01-01)

PRESENCIA DEL MARCADOR LMP-1 DEL VIRUS EPSTEIN-BARR EN LINFOMAS DE CANINOS
by: L. C. Veloza, et al.
Published: (2017-01-01)

镍、硒对Epstien-Barr病毒抗原表达的效应
Published: (1993-01-01)

Epstein-Barr病毒特异性DNA酶抗体(EDAb)水平检测在鼻咽癌早期发现中的提示性
Published: (1993-01-01)

Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration
by: Fuda Xie, et al.
Published: (2025-01-01)

Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
by: Twan Sia, BA, et al.
Published: (2025-05-01)

The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature
by: Gargee Mishra, et al.
Published: (2025-01-01)

The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Yue Zhou, et al.
Published: (2025-01-01)

Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosis
by: Amy Perrin Ross, et al.
Published: (2025-01-01)

MOG associated autoimmune encephalomyelitis with active disease dynamic in imaging examinations and minimal clinical manifestation
by: E. Tilindytė, et al.
Published: (2019-06-01)

Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein–Bar virus in host
by: Muhammad Naveed, et al.
Published: (2024-12-01)

Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis
by: Hui Chen
Published: (2025-01-01)

Epstein-Barr病毒特异性酶类及其抗体研究的进展
by: 黄迪
Published: (1990-01-01)

Association between composite dietary antioxidant index and Epstein–Barr virus infection in children aged 6–19 years in the United States: from the national health and nutrition examination survey 2007–2010
by: Wei Cheng, et al.
Published: (2025-01-01)

The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01)

A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
by: Ping Li, et al.
Published: (2025-01-01)

Corrigendum: A self-assembled nanoparticle vaccine elicits effective neutralizing antibody response against EBV infection
by: Ping Li, et al.
Published: (2025-02-01)

Paroxysmal sympathetic hyperactivity and refractory hypotension in Guillain-Barré syndrome with autoimmune encephalitis: a case report and literature review
by: Jun-Ping Wang, et al.
Published: (2025-02-01)

LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE.
by: kang sun
Published: (2024-04-01)

Optic Chiasmitis as an Isolated Manifestation of Myelin Oligodendrocyte Glycoprotein-Associated Disease – a Case Report
by: Nina Barankiewicz-Tyc, et al.
Published: (2024-10-01)

Myelin oligodendrocyte glycoprotein antibody-related disorders in children: association with optic neuritis and gender differences
by: K. Donielaitė-Anisė, et al.
Published: (2021-12-01)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)

Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
by: Febri Gunawan Sugiokto, et al.
Published: (2025-01-01)

First Indonesian Nasopharyngeal Cancer Whole Epigenome Sequencing Identify Tumour Suppressor CpG Methylation
by: Handoko, et al.
Published: (2025-01-01)

Biomarkers in Nasopharyngeal Carcinoma (NPC): Clinical relevance and prognostic potential
by: Madhan Krishnan, et al.
Published: (2024-09-01)

Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
by: Annie Elong Ngono, et al.
Published: (2015-01-01)

Survival and prognostic factors for primary lung extranodal NK/T-cell lymphoma: a retrospective study of data from China and the SEER database
by: Qiuyu Li, et al.
Published: (2025-01-01)

Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
by: Marie-Lynn Cuypers, et al.
Published: (2025-01-01)

Recurrent Bilateral Optic Neuritis Associated with Myelin Oligodendrocyte Glycoprotein Antibody: A Case Report from Nepal
by: Sangam Shah, et al.
Published: (2021-01-01)